Arbutus Biopharma Corp. (ABUS)
4.33
+0.10
(+2.36%)
USD |
NASDAQ |
Oct 20, 16:00
4.35
+0.02
(+0.46%)
Pre-Market: 08:28
Arbutus Biopharma Gross Profit (TTM) : 181.68M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 181.68M |
| March 31, 2026 | 191.40M |
| December 31, 2025 | 13.72M |
| September 30, 2025 | 13.92M |
| June 30, 2025 | 14.41M |
| March 31, 2025 | 5.048M |
| December 31, 2024 | 4.791M |
| September 30, 2024 | 5.336M |
| June 30, 2024 | 8.622M |
| March 31, 2024 | 11.56M |
| December 31, 2023 | 16.74M |
| September 30, 2023 | 20.89M |
| June 30, 2023 | 22.21M |
| March 31, 2023 | 31.76M |
| December 31, 2022 | 37.59M |
| September 30, 2022 | 34.43M |
| June 30, 2022 | 28.82M |
| March 31, 2022 | 14.97M |
| December 31, 2021 | 2.779M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 1.662M |
| December 31, 2014 | 5.958M |
| September 30, 2014 | 5.958M |
| June 30, 2014 | 5.958M |
| March 31, 2014 | 4.296M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Gossamer Bio, Inc. | 52.36M |
| Legend Biotech Corp. | 675.55M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |